1. Comparison of Paricalcitol With Maxacalcitol Injection in Japanese Hemodialysis Patients With Secondary Hyperparathyroidism. Issue 3 (3rd November 2014) Authors: Akizawa, Tadao; Akiba, Takashi; Hirakata, Hideki; Kinugasa, Eriko; Tominaga, Yoshihiro; Fukagawa, Masafumi; Yokoyama, Keitaro; Zhang, Wuyan; Linde, Peter G.; Suzuki, Masashi Journal: Therapeutic apheresis and dialysis Issue: Volume 19:Issue 3(2015) Page Start: 225 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Population Pharmacokinetics and Exposure‐Response Relationship of Luspatercept, an Erythroid Maturation Agent, in Anemic Patients With β‐Thalassemia. (21st July 2020) Authors: Chen, Nianhang; Kassir, Nastya; Laadem, Abderrahmane; Giuseppi, Ana Carolina; Shetty, Jeevan; Maxwell, Stephen E.; Sriraman, Priya; Ritland, Steve; Linde, Peter G.; Budda, Balasubrahmanyam; Reynolds, Joseph G.; Zhou, Simon; Palmisano, Maria Journal: Journal of clinical pharmacology Issue: Volume 61:Number 1(2021) Page Start: 52 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Population Pharmacokinetics and Exposure–Response of Luspatercept, an Erythroid Maturation Agent, in Anemic Patients With Myelodysplastic Syndromes. (30th June 2020) Authors: Chen, Nianhang; Kassir, Nastya; Laadem, Abderrahmane; Maxwell, Stephen E.; Sriraman, Priya; Giuseppi, Ana Carolina; Ritland, Steve; Linde, Peter G.; Budda, Balasubrahmanyam; Reynolds, Joseph G.; Zhou, Simon; Palmisano, Maria Journal: CPT: pharmacometrics & systems pharmacology Issue: Volume 9:Number 7(2020) Page Start: 395 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗